About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

AstraZeneca's Role in Nobel Prizes Is Questioned

By Jim Edwards | Dec 14, 2008

UPDATE — AstraZeneca failed to respond has now responded to BNET’s request for comment, see below. The company also provided a statement to Pharmalot. The company confirmed its sponsorship of Nobel organizations but denied it had influenced the judges: “Because the Nobel Committee of Karolinska Institute, and not the Nobel companies, elects candidates for the prize, AstraZeneca will not be able to influence who will be awarded the Nobel Prize, nor do we ever seek to.”

Swedish prosecutors are investigating allegations of a conflict of interest between AstraZeneca’s sponsorship of Nobel Foundation companies and the awarding of this year’s Nobel prize for medicine to the discoverer of human papilloma virus (HPV). AZ’s Medimmune unit helped develop markets* a vaccine for HPV, Cervarix, and receives roylaties from GlaxoSmithKline’s marketing of that drug. AZ also sponsors a Nobel program to highlight the work of Nobel winners. According to this report:

The head of the Nobel Committee says that the close link between the Nobel prize winner and a Nobel sponsor is new for them and needs to be discussed.

Details are scant, as much of the news is emerging from Europe in Swedish and German and is being spottily translated by U.S. bloggers. Here’s one example:

… there were reports that the three Nobel prize committees for the science prizes had received free flying tickets, hotels and dinners by the Japanese and Chinese governments in order for the committees to explain on site how they award a prize.

There was also criticism for the sponsor AstraZeneca having a board member involved in the medical committee deciding the winners. AstraZeneca stands to gain much money on the prized vaccines- but rightly so, as this research has been important. There is a difficult line of competences being drawn in many prizes, and the winning prizes can also be involved in applications ready for the markets.

Here’s another:

The Swedish Attorney-General will look into trips to China taken by  several members of Nobel Committees, where the expenses were paid by the hosts. The Department of Justice is looking into the possibility of bribery or attempted bribery. According to the Institute against Bribery, officials of the Nobel Foundation are obliged, under official Swedish ground rules, to cover those expense themselves.

Unfortunately, much of the translating and reporting is being done by fringe AIDS skeptics — people who believe that HIV does not exist or does not cause AIDS. (The Nobel also went to scientists who discovered HIV.) It would be nice to see some mainstream reporters pick this story up. In the meantime, we invite AstraZeneca to comment.

In an email to BNET, AstraZeneca spokesperson Zhou Yi said:

Swedish prosecutors are looking into the situation to see if there is a need to prepare for a case. No investigation has been launched yet.

UPDATE — Detailed report in English from HIV skeptic Celia Farber here.

* Original error was BNET’s; apologies.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

 
Reply to Story

BNET TalkbackShare your ideas and expertise on this topic

Subscribe to this discussion via Email or RSS

  •  
    1

    grtsales

    12/15/08 | Report as spam

    RE: AstraZeneca's Role in Nobel Prizes Is Questioned

    Nobel prizes are becoming questionable with another example being Paul Krugman's prize in economics or the one for Al Gore.

  •  
    2

    abishauser

    12/15/08 | Report as spam

    RE: AstraZeneca's Role in Nobel Prizes Is Questioned

    Actually, AZ markets Gardasil and GlaxoSmithKline markets Cervarix in the U.S.

  •  
    3

    abishauser

    12/15/08 | Report as spam

    RE: AstraZeneca's Role in Nobel Prizes Is Questioned

    Erm, scratch that. I'm clearly getting my cos mixed up. Big Pharma has me in a fever today!

  •  
    4

    BNET's Jim Edwards

    12/15/08 | Report as spam

    RE: AstraZeneca's Role in Nobel Prizes Is Questioned

    It is confusing. Here's the correct info:

    - AZ's Medimmune unit helped develop Cervarix.

    - Cervarix is marketed by GSK.

    - (Merck markets a rival product, Gardasil, which is completely uninvolved in this story.)

  •  
    5

    michael0156

    09/02/09 | Report as spam

    RE: AstraZeneca's Role in Nobel Prizes Is Questioned

    Actually there is at least one tie to Merck in this mess. Two former Merck executives Friend and Schadt started a company SAGE in Seattle Washington. A member of the board? Hans Wigzell, of the Karolinska Institute, current researcher, former President, and Professor Emeritus.

    Many scientists are honest hard working, with their integrity intact. Many are just as greedy and unscrupulous as pharmaceutical executives. Big Pharma makes sure that is the only way to get ahead in the world of medicine.

    The Nobel board knew the value to Merck of Hausen getting the "Prize". I'm sure they made Merck pony-up plenty for that fraudulent award, along with Glaxo. Astrazeneca was not left alone to pay the bills.

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement